H.C. Wainwright Downgrades Melinta Therapeutics Inc. (MLNT) to Neutral Following CEO Resignation
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce downgraded Melinta Therapeutics Inc. (NASDAQ: MLNT) from Buy to Neutral.The analyst comments "While management would ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
